Drugs & medicalClass II

SUN PHARMACEUTICAL INDUSTRIES INC recalls buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceutical…

Failed Dissolution Specifications; during stability testing

Read the official notice →
Date
2023-05-31
Country
United States
Brand
Sun Pharmaceutical Industries
Product
buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceutical Industries,…
Classification
Class II
Units
Nationwide in the U.S.A
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Sun Pharmaceutical Industries recalls

  1. 2023-07-19
  2. US
    Drugs & medicalClass II

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Tiagabine Hydrochloride Tablets, 2 mg, 30-count bottle, Distributed by Sun Pharmaceutical Industries. Inc. Cranbury NJ 08512,…

    Failed Impurities: Out of Specification (OOS) result observed during Related Substances testing

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCDistributed nationwide in the USA.Official notice →
  3. 2023-07-05
  4. US
  5. 2023-06-14
  6. US
    Drugs & medicalClass II

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83.

    CGMP Deviations

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCProduct was distributed to 19 distributors nationwide.Official notice →
  7. 2023-05-03
  8. US
    Drugs & medicalClass II

    Sun Pharmaceutical Industries Ltd. recalls Fyremadel (ganirelix acetate) injection, 250 mcg/0.5 mL, One Single Dose Sterile Prefilled Syringe 0.5 mL, For Subcutaneous…

    Presence of Particulate Matter: A piece of glass was found in a prefilled syringe.

    FDA · DrugSun Pharmaceutical Industries Ltd.Nationwide in the USAOfficial notice →
  9. 2023-04-19
  10. US
    Drugs & medicalClass III

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Norepinephrine Bitartrate Injection, USP, 4 mg/4 mL* (1 mg/mL), 4 mL Single-dose Fliptop Vial (NDC 47335-615-40); packaged in…

    Failed Impurities/Degradation Specifications: Above the specification limits yielded for related substance norepinephrine sulfonic acid impurity during routine product monitoring.

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCNationwide in the USAOfficial notice →
  11. 2023-03-29
  12. US
    Drugs & medicalClass III

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Dofetilide Capsules, 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured by: Sun Pharmaceutical Industries Limited,…

    Failed Content Uniformity Specifications

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCUSA nationwide.Official notice →
All 57 Sun Pharmaceutical Industries recalls →

Other drugs & medical recalls in the United States

  1. 2023-05-31
  2. US
  3. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc. recalls Pain Reliever, Acetaminophen USP Caplets, 500 mg, 225-count bottles packaged in a cardboard carton, Distributed by: Walgreen Co., 200…

    Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.

    FDA · DrugAurobindo Pharma USA Inc.The recalled product was distributed to one Retail Distributor (Walgreens) who…Official notice →
  4. US
  5. US
    Drugs & medicalClass II

    Alpha Aromatics recalls FOAMING HAND SANITIZER, fresh mint scent, 62% alcohol, 1 Gallon / 3.78 Liters bottle, 290 Alpha Drive RIDC industrial Park, Pittsburgh, PA…

    CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

    FDA · DrugAlpha AromaticsProduct was distributed to one account in NC.Official notice →
  6. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00; b) 500-count bottle, NDC# 68001-179-03,…

    CGMP Deviations: recalling drug products following an FDA inspection.

    FDA · DrugAmerisource Health Services LLCNationwide USAOfficial notice →
  7. US
    Drugs & medicalClass III

    Amneal Pharmaceuticals of New York, LLC recalls Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and Soft Tissue…

    Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number 70121-1573-1; Correct NDC Number…

    FDA · DrugAmneal Pharmaceuticals of New York, LLCNationwide in the USA and PROfficial notice →
See all drugs & medical recalls →